Early blood biomarkers to diagnose acute stroke could drastically reduce treatment delays.
We investigated whether circulating small non-coding RNAs can serve as biomarkers to …

Rationale: Currently, there are no blood-based biomarkers with clinical utility for acute
ischemic stroke (IS). MicroRNAs show promise as disease markers because of their cell type …

Background Many diseases include microRNAs (miRNAs) as reported biomarkers. The
significance of circulating miRNAs for early diagnosis of acute stroke in humans is unknown …

Background and Purpose Stroke is the second leading cause of death and disability
worldwide and its diagnosis, and assessment of prognosis, remains challenging. There is a …

Long noncoding RNAs (lncRNAs) have been highlighted to be involved in the pathological
process of ischemic stroke (IS). The purpose of the present study was to investigate the …

Background and aims Circulating microRNAs (miRNAs) have recently emerged as
promising biomarkers for acute ischaemic stroke (AIS). However, the expression profiles of …

Transient ischemic attack (TIA) refers to a momentary neurologic deficit caused by focal
cerebral, spinal or retinal ischemic insult. TIA is associated with a high risk of impending …

Ischemic strokes are associated with significant morbidity and mortality, but currently there
are no reliable prognostic or diagnostic blood biomarkers. MicroRNAs (miRNAs) regulate …

Background Acute ischemic stroke is a leading cause of death and disability worldwide.
Unlike myocardial infarction, there is no current blood test to diagnose acute ischemic …

Background Recent studies have demonstrated that dysregulated non-coding RNAs
(ncRNAs) are involved in the pathogenesis of ischemic stroke (IS), including …